Further, the Company's research and development efforts are expected to result in new products that will enhance the revenue stream, new technology that will advance manufacturing efficiency, and cost-cutting distribution methods that will facilitate sales and accelerate deliveries. The Company is aggressively seeking accretive acquisitions and is currently engaged in preliminary talks with companies producing proprietary medical and insurance products and services.
Healthnostics, Inc. (PINKSHEETS: HNSS) has commenced discussions with a Fortune 500 company regarding rights and royalties to manufacture and distribute a Healthnostic-patented liquid fill product. The Company is confident in the market viability of this unique product and the significant cost-free revenue stream it can produce. This product is new and is designed to appeal to a diverse and widespread market, which is why the Company has decided to join with a major international manufacturer to produce and distribute it. In this way the product will come more quickly to a broad-based market and potentially generate near and long term revenue streams.
Healthnostics in Acquisition Discussions
Healthnostics, Inc. (PINKSHEETS: HNSS) has been approached by a publicly-traded corporation seeking to acquire the Company for a minimum target price of $.01 per share. It is expected that these negotiations will be completed over the next 30 days.
Notice how the company was in preliminary talks with companies producing proprietary medical and insurance products and services in early February of 2011. These negotiations were described as the company aggressively seeking accretive acquisitions. Also note that the PR described new products that would be available for the market during 2011.
Now note that HNSS was in contact with a Fortune 500 company in order to market a new patented product that HNSS developed and wants to put on the market during 2011.
The final PR shows that a publicly-traded corporation is interested in the purchase of HNSS.
Are all of these PRs describing the same company that is interested in the purchse of HNSS?
Does this company produce proprietary medical and insurance products and services?
Is this company a Fortune 500 company? It is likely that a Fortune 500 company would be publicly-traded and the time frame between 'preliminary' negotiations and 'final' negotiations would fit right in line with the time frame from early February till now (6-7 months).
Market Data 
Markets 
